Bridgefront Capital, LLC Kala Pharmaceuticals, Inc. Transaction History

Bridgefront Capital, LLC

  • $236 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$2.62 - $5.43 $124,630 - $258,299
-47,569 Closed
0 $0
Q2 2021

Aug 12, 2021
SELL
$5.06 - $8.15 $19,314 - $31,108
-3,817 Reduced 7.43%
47,569 $252,000
Q1 2021

May 17, 2021
BUY
$6.24 - $9.58 $144,287 - $221,518
23,123 Added 81.81%
51,386 $346,000
Q4 2020

Feb 12, 2021
BUY
$6.28 - $8.79 $177,491 - $248,431
28,263 New
28,263 $192,000

Others Institutions Holding KALA

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0
View Full List

About Kala Pharmaceuticals, Inc.

KALA Quotes by TradingView
  • Ticker KALA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,464,160
  • Market Cap $7.69M
  • Description
  • Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...
More about KALA
Track This Portfolio

Track Bridgefront Capital, LLC Portfolio

Follow Bridgefront Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgefront Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgefront Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email